| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.04 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.32 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |